Lv11
92 积分 2023-10-16 加入
Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis
3小时前
已完结
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
14天前
已完结
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
14天前
已完结
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
17天前
已完结
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
20天前
已完结
Clinical Characteristics of Hand Eczema and its Association with Atopic Dermatitis in the Chinese Population: A Multicenter Cross-Sectional Study
25天前
已完结
IL-17A抑制剂相比阿达木单抗治疗银屑病关节炎的临床研究
1个月前
已完结
结节性痒疹诊疗指南
1个月前
已完结
特应性皮炎及其共病的多学科全病程管理专家共识（2026版）
1个月前
已完结
严重过敏反应诊断和临床管理专家共识
1个月前
已完结
皖公网安备34019202002308
